CVS HealthLIM:CVS 62 EV-to-FCF is 27.09 as of Jul. 03, 2026, which is 77% above its 10-year median of 15.32. GuruFocus rates LIM:CVS with a GF Score™ of 62/100 and a GF Value™ of $75.93 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 17 Healthcare Plans companies, CVS Health ranks worse than 76.47% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CVS Health's Enterprise Value is $200,339 Mil.
CVS Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $7,394 Mil. Therefore, CVS Health's EV-to-FCF for today is 27.09.
The historical rank and industry rank for CVS Health's EV-to-FCF or its related term are showing as below:
LIM:CVS'
s EV-to-FCF Range Over the Past 10 Years
Min: 8.41 Med: 15.32 Max: 93.11
Current: 27.09
During the past 13 years, the highest EV-to-FCF of CVS Health was 93.11. The lowest was 8.41. And the median was 15.32.
LIM:CVS's EV-to-FCF is ranked worse than 76.47% of 17
companies
in the Healthcare Plans industry
Industry Median: 20.01
vs LIM:CVS: 27.09
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CVS Health's share price for today is $102.35.
CVS Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.270.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CVS Health EV-to-FCF Related Terms
CVS Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for CVS Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, CVS Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Health EV-to-FCF vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, CVS Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where CVS Health's EV-to-FCF falls into.
CVS Health's current Enterprise Value is $200,339 Mil.
CVS Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $7,394 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Health (LIM:CVS) has a EV-to-FCF of 27.09 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on CVS Health and its competitors. This is 77% above median its historical median of 15.32. Over the past decade, CVS Health's EV-to-FCF has ranged from 8.41 to 93.11. According to the industry distribution chart, CVS Health ranks #13 out of 17 companies in the Healthcare Plans industry, placing it in the top 76.5%.
Is CVS Health's EV-to-FCF too high?
CVS Health's current EV-to-FCF of 27.09 is 77% above median its 10-year median of 15.32. Over the past 10 years, this metric has ranged from a low of 8.41 to a high of 93.11. The Healthcare Plans industry median EV-to-FCF is 20.01. CVS Health's value of 27.09 is 35.4% above this industry median. Based on the distribution chart, CVS Health ranks #13 out of 17 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, CVS Health has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's EV-to-FCF compare to ELV and CI?
According to the Healthcare Plans industry distribution chart, CVS Health ranks #13 out of 17 companies for EV-to-FCF. This places CVS Health in the lower half of its industry. The industry median EV-to-FCF is 20.01. CVS Health's value of 27.09 is 35.4% above this benchmark. Historically, CVS Health's own EV-to-FCF has ranged from 8.41 to 93.11 over the past decade. While the company's 10-year median is 15.32 vs. the industry median of 20.01, CVS Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Plans company?
The median EV-to-FCF among Healthcare Plans companies is 20.01, based on 17 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Health's current EV-to-FCF of 27.09 is 35.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on CVS Health and its competitors. For the Healthcare Plans industry, the median EV-to-FCF is 20.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Health's current EV-to-FCF is 27.09, which is 77% above median its own 10-year median of 15.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (LIM:CVS) is currently considered Significantly Overvalued. The stock's GF Value™ is $75.93, compared to a current price of $102.35 — trading 34.8% above its estimated fair value. The current EV-to-FCF is 27.09, which is 77% above median its 10-year median of 15.32 and 35.4% above the Healthcare Plans industry median of 20.01. CVS Health's overall GF Score™ is 62/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For CVS Health (LIM:CVS), the current EV-to-FCF is 27.09 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Health (LIM:CVS) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Health stock appears to be overvalued.
The current stock price of $102.35 is trading 34.8% above its estimated GF Value™ of $75.93.
GuruFocus considers CVS Health to be Significantly Overvalued.
Key valuation signals for LIM:CVS:
EV-to-FCF: 27.09 (77% above median its 10-year median of 15.32)
GF Value™: $75.93 vs. price of $102.35 (34.8% above fair value)
Industry Position: 35.4% above the Healthcare Plans median (#13 of 17)
No single metric tells the full story. See the LIM:CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
62GF Score
Get the complete analysis for LIM:CVS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LIM:CVS has been successfully added to your 
